News Conference News ACC 2025 Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years L.A. McKeown March 30, 2025
News Conference News STS 2025 Amid Declining Use, Mechanical SAVR Valves Beat Bioprosthetic for Survival Yael L. Maxwell January 27, 2025
News Conference News AHA 2024 ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery Yael L. Maxwell November 17, 2024
News Conference News TAVI Use Rising in Young US Patients, Yet Another Analysis Shows Yael L. Maxwell May 06, 2024
News Conference News STS 2024 Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3 Yael L. Maxwell February 09, 2024
News Conference News STS 2024 TAVI, SAVR Almost Equally Performed in California Patients Under 60 Yael L. Maxwell February 01, 2024
News Conference News TCT 2023 Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3 Michael O'Riordan November 01, 2023
News Conference News TCT 2023 Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials Michael O'Riordan October 24, 2023
News Conference News EACTS 2023 AUTHEARTVISIT Reignites RCT vs Real-world Data Debate for AV Repair Michael O'Riordan October 09, 2023
News Conference News STS 2022 Transcatheter Mitral Valve-in-Valve a ‘Good Option’, but With Higher Gradients Todd Neale February 02, 2022
News Conference News AHA 2021 AVATAR Supports Early SAVR in Asymptomatic Severe AS Patients L.A. McKeown November 13, 2021
News Conference News EACTS 2021 More Deaths With Bioprosthetic Than Mechanical AVR in Young AS Patients Michael O'Riordan October 18, 2021
News Conference News TVT 2020 Device Explants After TAVR Rare but Risky Michael O'Riordan June 24, 2020
News Conference News STS 2020 For Congenital Heart Disease, SAVR With Bioprosthetic Valve Still Reigns Yael L. Maxwell January 30, 2020
News Conference News STS 2019 Redo Surgery for Bioprosthetic Aortic Valve Failure on the Decline Since 2015 Yael L. Maxwell February 06, 2019